Literature DB >> 12899321

Measuring emotional intelligence with the MSCEIT V2.0.

John D Mayer1, Peter Salovey, David R Caruso, Gill Sitarenios.   

Abstract

Does a recently introduced ability scale adequately measure emotional intelligence (EI) skills? Using the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT; J. D. Mayer, P. Salovey, & D. R. Caruso, 2002b), the authors examined (a) whether members of a general standardization sample and emotions experts identified the same test answers as correct, (b) the test's reliability, and (c) the possible factor structures of EI. Twenty-one emotions experts endorsed many of the same answers, as did 2,112 members of the standardization sample, and exhibited superior agreement, particularly when research provides clearer answers to test questions (e.g., emotional perception in faces). The MSCEIT achieved reasonable reliability, and confirmatory factor analysis supported theoretical models of EI. These findings help clarify issues raised in earlier articles published in Emotion.

Mesh:

Year:  2003        PMID: 12899321     DOI: 10.1037/1528-3542.3.1.97

Source DB:  PubMed          Journal:  Emotion        ISSN: 1528-3542


  179 in total

Review 1.  The expression of emotion through nonverbal behavior in medical visits. Mechanisms and outcomes.

Authors:  Debra L Roter; Richard M Frankel; Judith A Hall; David Sluyter
Journal:  J Gen Intern Med       Date:  2006-01       Impact factor: 5.128

2.  Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects.

Authors:  Shaun M Eack; Gerard E Hogarty; Deborah P Greenwald; Susan S Hogarty; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2006-10-19       Impact factor: 4.939

3.  Neural correlates of emotional intelligence in adolescent children.

Authors:  William D S Killgore; Deborah A Yurgelun-Todd
Journal:  Cogn Affect Behav Neurosci       Date:  2007-06       Impact factor: 3.282

Review 4.  The assessment of alexithymia in medical settings: implications for understanding and treating health problems.

Authors:  Mark A Lumley; Lynn C Neely; Amanda J Burger
Journal:  J Pers Assess       Date:  2007-12

5.  Effects of Cognitive Enhancement Therapy on Employment Outcomes in Early Schizophrenia: Results From a Two-Year Randomized Trial.

Authors:  Shaun M Eack; Gerard E Hogarty; Deborah P Greenwald; Susan S Hogarty; Matcheri S Keshavan
Journal:  Res Soc Work Pract       Date:  2011-01-27

6.  One-year durability of the effects of cognitive enhancement therapy on functional outcome in early schizophrenia.

Authors:  Shaun M Eack; Deborah P Greenwald; Susan S Hogarty; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2010-05-15       Impact factor: 4.939

7.  The neural bases of key competencies of emotional intelligence.

Authors:  Frank Krueger; Aron K Barbey; Kevin McCabe; Maren Strenziok; Giovanna Zamboni; Jeffrey Solomon; Vanessa Raymont; Jordan Grafman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

8.  Brief report: is cognitive rehabilitation needed in verbal adults with autism? Insights from initial enrollment in a trial of cognitive enhancement therapy.

Authors:  Shaun M Eack; Amber L Bahorik; Susan S Hogarty; Deborah P Greenwald; Maralee Y Litschge; Carla A Mazefsky; Nancy J Minshew
Journal:  J Autism Dev Disord       Date:  2013-09

9.  Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.

Authors:  Gregory P Strauss; William P Horan; Brian Kirkpatrick; Bernard A Fischer; William R Keller; Pinar Miski; Robert W Buchanan; Michael F Green; William T Carpenter
Journal:  J Psychiatr Res       Date:  2013-02-27       Impact factor: 4.791

10.  Cognitive enhancement therapy for adults with autism spectrum disorder: results of an 18-month feasibility study.

Authors:  Shaun M Eack; Deborah P Greenwald; Susan S Hogarty; Amber L Bahorik; Maralee Y Litschge; Carla A Mazefsky; Nancy J Minshew
Journal:  J Autism Dev Disord       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.